I bought a $150,000 position in Crinetics Pharmaceuticals (NASDAQ: CRNX) for our biotech hedge fund over 2.5 years ago. During that time, not much happened. More than once, I considered selling the position and redeploying that capital into another opportunity. I’m glad I didn’t. Instead, I trusted our investment process. I knew that when we...
Dear Investors, I’m pleased to let you know that your June 2026 financial report has now been released. June was a very strong month for Evergrowth BioHealthcare Capital, and I believe you’ll be pleased with the results. Historically, biotech stocks tend to trade sideways—or even weaken—during the summer months before beginning a more robust rally...
Are you a hardworking professional working day in and day out, hoping your retirement savings will one day let you live comfortably without pinching pennies? You’ve probably followed the “safe” advice: park your money in index funds, mutual funds, bonds, or hand it over to a registered investment advisor (RIA) or a big-name Wall Street...
I am delighted to share an update on the strong performance of Evergrowth BioHealthcare Capital. Since inception, the fund has delivered gross returns exceeding 83%, and year-to-date through December 2025, we have achieved gross returns over 24%. These outstanding results reflect the disciplined and research-driven strategy. As Christmas and the New Year draw near, my...
As a physician-turned-investor managing a biotech hedge fund, I’ve watched many smart colleagues (and investors in general) dive into the exciting world of stock charts. Patterns like “head and shoulders,” moving averages, or RSI indicators can feel sophisticated—especially with multiple screens lighting up your desk. When my daughter Hannah was a baby singing “Head, Shoulders,...
Dear Fellow Physicians, You’ve heard the timeless investing mantra: “Buy low, sell high.” It’s deceptively simple—yet most investors, even highly trained professionals like you, end up doing precisely the opposite. Why? Because fear is the most powerful emotion in markets.When a stock (or an entire sector) is spiraling lower, fear screams that it will go...
It is with great pleasure that we welcome Dr. Victoria Mondloch to Evergrowth’s Medical and Scientific Advisory Board. Dr. Mondloch is a distinguished OB/GYN physician, consultant, and author, bringing decades of clinical and advisory experience to the table. We are incredibly fortunate to have her insights and leadership as we continue to grow Evergrowth’s biotech...
Physician investors, let’s talk stocks. When you hear “stocks,” what comes to mind? Flashing trading screens, technical charts, or maybe the adrenaline rush of day trading? Be honest with yourself: when you’re trading stocks, have you consistently pulled off 20% annual returns over the years? If you’re nodding yes, I’m calling your bluff. But if...
If you’re a doctor aiming for early retirement through biotech investing, let me ask you this: Is short-term trading better than buying and holding for the long term? My experience points to a clear answer. But let me share with you a video on trading. Despite the illusion of sophistication, it’s extremely stressful and can...
Fellow physicians! If you’re dreaming of an early, luxurious retirement—sipping coffee on a beach instead of charting at 2 a.m.—you already know what to invest in is only half the battle. The other half? Knowing what not to touch. One wrong move, and you’re not just out money—you’re set back years, stuck working longer than...